Maraninchi to be Marimbert's replacement at France's medicines regulator, Afssaps
This article was originally published in Scrip
Dominique Maraninchi, currently head of France's national cancer institute (INC), is to head up the country's medicines regulator, Afssaps, a French government source, who wished to remain anonymous, told Scrip. Afssaps is to have two directors, although it is unclear who will join Professor Maraninchi at the helm.
You may also be interested in...
Public health advocates say that commercial concerns must take a back seat to health interests if COVID-19 technologies are to be made available to those who need them. But industry says that relaxing IP protections is not the solution and that many companies have already invested significant amounts of money in potential new treatments and vaccines.
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
Intellectual property rights are under the microscope as countries prepare to provide affordable and timely access to pandemic technologies.